InvestorBrandNetwork (IBN) Content Platform – The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

420 with CNW — Free Cannabis for COVID Jabs Turns Out to Be Popular

May 14, 2021

May 14, 2021 15:25:08

The latest data from the U.S. CDC indicates that approximately one-third of all adults in the country have received full vaccination against COVID-19. As the statistics of doses administered on a daily basis start dropping, health officials have turned their focus upon individuals who express hesitation to get the jab.

Smaller vaccination centers are mushrooming in a number of unexpected places, such as at strip clubs, to lure more people to get vaccinated. At the same time, people are being given different incentives to encourage them to get vaccinated. Incentives include savings bonds, cash and, in some…

Australian Team Develops Mining Technique That Uses Magnetic Fields Rather Than Digging

May 14, 2021

May 14, 2021 15:05:17

Scientists from the University of Exeter, the Technical University of Denmark, CSIRO (which is the national science agency in Australia) and the University of Western Australia have designed a new mining method that extracts minerals from hard rock ore using electric fields.

The method could replace the conventional digging technique, which causes significant effects to the environment. These include biodiversity loss, formation of sinkholes, deforestation, erosion and the contamination of ground, soil and surface water…

NetworkNewsAudio — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Creates Digital Face of Plant-Based Community

May 14, 2021

May 14, 2021 14:50:25

The exploding interest in all things plant-based has taken root around the world. And the trend is about much more than eliminating meat from concerned consumers’ diets. For millions of people, choosing plant-based products is a holistic lifestyle that reflects not only healthy eating habits but a commitment to social and sustainability values as well. As proof, recent research shows that ads highlighting the social costs of meat consumption are more influential in swaying a person to a plant-based meat alternative than those emphasizing taste. The concept of an all-encompassing way of living is at the heart of PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (Profile), a rapidly growing company founded by serial entrepreneur Sean Dollinger as the digital face of the plant-based community and a one-stop shop for all things plant-based. The focus on putting people and planet first is a common thread running through the plant-based foods sector, a philosophy embraced by consumers to drive growth for manufacturers such as Beyond Meat Inc. (NASDAQ: BYND), Tattooed Chef Inc. (NASDAQ: TTCF), Laird Superfood Inc. (NYSE American: LSF) and Burcon Nutrascience Corp. (OTCQB: BUROF).

To hear the NetworkNewsAudio version, visit https://nnw.fm/XQuYH

To view the full editorial, visit https://nnw.fm/9fY6E

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s website at www.Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://nnw.fm/PLTXF

About NetworkNewsAudio

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

For more information, visit www.NetworkNewsAudio.com

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

ChineseNewsBreaks – Infobird Co. Ltd.’s (NASDAQ: IFBD) New SaaS Model Designed to Expand Customer Base, Capture More Market Share

May 14, 2021

May 14, 2021 14:07:57

Infobird (NASDAQ: IFBD), a leading artificial intelligence (“AI”) software-as-a-service (“SaaS”) provider is positioned for opportunity amid a wave of digital transformation sweeping across China. In the last two decades, the company has gleaned tremendous experience and achieved significant technological advances and service capabilities while providing customized SaaS products to some of China’s largest and most demanding financial institutions. With that solid foundation in place, Infobird recently implemented a strategic transition to standardized module SaaS with the intent to expand its customer base and quickly capture additional market share. “Standardized module SaaS has the characteristics of fast scale up and low cost compared to customized SaaS,” reads a recent article on the transition. “The strategic transformation of Infobird from customized SaaS to standardized module SaaS not only replicates its past success serving large financial institutions to large customers across industries, but also promotes its SaaS to many more small and medium-sized enterprises in China.” This enables businesses that cannot afford expensive customized SaaS to benefit from high-quality standard AI-powered SaaS customer engagement solutions.”

To view the full article, visit https://ibn.fm/anrP1

About Infobird Software Co. Ltd.

Infobird, headquartered in Beijing, China, is a software-as-a-service provider of innovative AI-powered or enabled customer engagement solutions. For more information about the company, visit www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: http://IBN.fm/Disclaimer

ChineseWire (CW)
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Maine Senate Bill Could Legalize Psilocybin Mushroom Therapy for Adults

May 14, 2021

May 14, 2021 14:05:22

A bill that was recently introduced in Maine will legalize psilocybin’s therapeutic use and establish a licensed industry for the drug. Psilocybin is the main active compound found in magic mushrooms.

Introduced by State Sen. Donna Bailey, the Maine Psilocybin Services Act will permit individuals aged 21 and above to legally buy psilocybin products and ingest them under the supervision of psilocybin service providers who are licensed…

An Infant’s First Stool May Be Used to Predict Their Future Health

May 14, 2021

May 14, 2021 13:52:36

A recent study by a group of researchers from the University of British Columbia has found that the composition of meconium can be used to find out whether a baby will develop allergies as they get older. Meconium, which is a child’s first poop, is a thick dark-green substance. The research was reported in the Cell Reports Medicine journal.

Dr. Brett Finlay, a professor from the university’s departments of immunology, microbiology, molecular biology and biochemistry, explained that the analysis they conducted showed that compared with babies who didn’t develop allergic sensitization, those who did had considerably…

Georgia Prepares to Play Major Role in EV Industry

May 14, 2021

May 14, 2021 13:46:13

After plugging along for more than a century, the internal combustion engine (“ICE”) vehicle is finally being retired. Several countries around the world have pledged to replace the vehicles with zero-emission battery electric vehicles (“BEVs”) over the next decade or two. The industry is still pretty young, however, with electric vehicles (“EVs”) making up only 3% of all the vehicles on the globe.

Fortunately, most industry experts predict increased electric vehicle sales as the automobiles become more affordable. The state of Georgia is poised to play a major role in the EV space. According to the International Energy Agency, electric vehicles worldwide will hit 116 million units in 2030, up from 8.5 million and making up nearly 60% of all miles traveled by passenger…

InvestorNewsBreaks – Wave Life Sciences Ltd. (NASDAQ: WVE) Featured in Mizuho Securities Research Report

May 14, 2021

May 14, 2021 13:07:53

Wave Life Sciences (NASDAQ: WVE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “This morning, WVE held its 1Q21 call. We also had the opportunity to catch up with management post the call. The most important takeaway from today’s call is that we now have a timeline as to when we can expect at least initial clinical data from Wave’s new PN-chemistry based pipeline program(s) — 2022. It’s starting to set up as potentially as a really important year for the company in our view, if they produce multiple datasets, which seems possible to us given multiple trials will begin dosing in 2021. And when we consider that Wave is pursuing rare disease of unmet need, and Wave is using adaptive design, we are starting to consider whether such trial(s) could be converted to registrational and stand on their own. Details below.”

To request access to the full report, visit https://ibn.fm/MruSz

About Wave Life Sciences Ltd.

Wave Life Sciences (NASDAQ: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.WaveLifeSciences.com and follow Wave on Twitter @WaveLifeSci.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

BioMedNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Focuses ‘Covid-ID Lab’ Commercialization Strategy Initially on German Market

May 14, 2021

May 14, 2021 12:45:05

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently entered a strategic distribution, storage and logistics agreement for its commercial 25-minute COVID-19 RT-PCR test system (“Covid-ID Lab”). In April, XPhyto announced its entry into the agreement with a full-fledged German pharmaceutical wholesaler and service provider. Under the agreement, the German partner will distribute, store and deliver Covid-ID Lab test kits to XPhyto’s customers in line with product specifications and relevant logistical and regulatory requirements in Germany. A recent article quotes XPhyto CEO and Director Hugh Rogers, who noted that the company had secured a strong partner with an existing network. “The company’s commercialization strategy is focused on the German market for initial product launch and the creation of robust and sustainable sales,” he said. The German market shows promise in ramping up XPhyto’s sales revenue, as the country’s slow vaccination rollout has resulted in persistent testing requirements.

To view the full article, visit https://ibn.fm/V5t35

About XPhyto Therapeutics Corp.

XPhyto Therapeutics works with the most promising disrupters in the pharmaceutical industry; accelerates research and technology development; and commercializes products with an entrepreneurial approach and a commitment to efficiency, effectiveness and accessibility. The company’s network spans Europe and North America, with companies at the forefront of diagnostics and drug formulations, and universities specializing in research on the use of psychedelics and cannabinoids. To learn more, visit the company’s website at www.Xphyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

InvestorNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Latest Acquisition Brings in Innovative Team of Experts

May 14, 2021

May 14, 2021 12:42:37

Healthtech Solutions (OTC: HLTT), focused on acquiring and investing in strategic cutting-edge health care technological opportunities, is among biotech players that have pivoted to a new model wherein multiple portfolio companies operate under one parent organization. Healthtech’s latest acquisition, Varian Biopharmaceuticals, brings to three the number of subsidiaries under its umbrella. “The acquisition of Varian by Healthtech plays to the strengths of the new portfolio model not only in drug pipeline but also by bringing in experts in an area that could attract additional investment,” reads a recent article. A precision oncology company, Varian specializes in developing atypical protein kinase C iota (“aPKCi”) inhibitors for different tumor types. Its two lead candidates are being prepared for clinical trials. The article quotes Healthtech CEO and Chairman David Rubin as saying, “The fact that [Varian Bio is] developing therapies to target difficult-to-treat cancers such as pancreatic cancer demonstrates just how innovative their team is.”

To view the full article, visit https://ibn.fm/Wi77m

About Healthtech Solutions Inc.

Healthtech Solutions is a reporting public company. The board of directors is focusing the company’s resources into creating a platform to acquire and/or invest in cutting-edge health care technology in the medical device biopharma and pharmaceutical fields. The goal is to bring these solutions to market.

To date, Healthtech Solutions has invested in three areas of medical technology breakthrough:

MediScan Inc., which is developing a technology that converts 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The goal is a commercial system that can provide the data equivalent to an X-ray, MRI or CT scan, without radiation and at a lower cost.
RevHeart Inc., which is advancing critical research into the treatment of COVID-related heart muscle injury.
Varian Biopharmaceuticals Inc., a precision oncology company, is the first acquisition of Healthtech Oncology Inc.

Healthtech Solutions has a pipeline of additional acquisitions currently under due diligence.

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

About InvestorWire

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Radically Different Cultivation Approach

May 14, 2021

May 14, 2021 12:09:19

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) has sought to differentiate itself by focusing on a genetics-based cultivation approach that enables production of premium-quality strains and products. This focus is influenced by the company’s resolution to avoid the fate that has befallen its competitors that have seen recent declines in market share. According to a recent article, PACR’s genetics-based cultivation approach has allowed it “to produce 50 super-elite strains and roughly 350 tested cultivars, which in turn has resulted in the company maximizing yields, boosting profitability and minimizing labor costs. In fact, as Pac Roots CEO explained, the company’s cultivation processes differed radically relative to any of its peers.”

To view the full article, visit https://cnw.fm/3vXE7

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners: Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CryptoNewsBreaks – CryptoCurrencyWire’s Selected as Official Newswire, Media Sponsor for AIBC UAE Summit

May 14, 2021

May 14, 2021 12:06:09

CryptoCurrencyWire (“CCW”), a multifaceted financial news and publishing company that is part of the InvestorBrandNetwork (“IBN”), has been named as an official newswire for the upcoming AIBC UAE Summit; CCW has also been designated as an official media sponsor for the two-day event. CCW will be collaborating with SiGMA Group on its coverage and communication. The premier conference is scheduled for May 25–26 and will be held at the InterContinental Dubai Festival City Hotel located in Dubai, U.A.E. The summit is designed to bring together key companies and individuals artificial intelligence (“AI”), blockchain, IoT (“IoT”) and quantum tech and create a forum for discussion about the emerging tech and networking opportunities for those working and interested in the space. The AIBC UAE Summit has gained a reputation as one of the leading global events for blockchain, AI, crypto and other related technologies, and brings together an elite selection of delegates, policymakers and thought leaders from around the world. The agenda for this year’s summit features a twin-track conference and workshop series and will include topics such as “Regulation & Compliance,” “DeFi & Fintech Future Trends” and “Emerging Tech & AI Integration” as well as workshops that cover NFTs, blockchain training and dev tech talk. The announcement noted that IBN and CCW will work together to leverage their impressive array of corporate communications solutions to expand recognition for conference participants. Communication strategies include wire-grade press releases and multiple full-length articles with amplified article syndication across CCW’s 5,000-plus distribution partner network. “We are delighted to be working with the SiGMA team,” said CCW director of communications Jonathan Keim in the press release. “This conference will feature some of the blockchain industry’s greatest innovations on display, with some of the sector’s most outstanding businesses and players in attendance, all of which makes this a standout event in the blockchain space and well worth attending.”

To register for the event, visit https://ccw.fm/4RoFu

To view the full press release, visit https://ccw.fm/ZA8K9

About CryptoCurrencyWire

CryptoCurrencyWire is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with CCW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness. CryptoCurrencyWire is where news, content and information converge via crypto. For more information about the company, visit www.Cryptocurrencywire.com. About CryptoCurrencyWire (“CCW”) CryptoCurrencyWire (CCW) is a financial news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with CCW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness. To receive instant SMS alerts, text CRYPTO to 77948 (U.S. Mobile Phones Only) CryptoCurrency News Wire is where News, content and information converge via Crypto. For more information, please visit https://www.CryptoCurrencyWire.com Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published: http://CCW.fm/Disclaimer CryptoCurrencyWire (CCW) New York, New York www.CryptoCurrencyWire.com 212.994.9818 Office Editor@CryptoCurrencyWire.com CryptoCurrencyWire is part of the InvestorBrandNetwork

Mobius Interactive Ltd. Brazil Launch – FIFA World Cup Soccer Qualifiers

May 14, 2021

May 14, 2021 11:46:24

Mobius.Bet will be showcased in all 8 stadiums during the Brazil FIFA World Cup Soccer qualifiers – the opening salvo of its launch into the lucrative Brazilian market
There will be an estimated 35 to 40 million viewers per match
With over 76 million gamers, Brazil is the largest and fastest-growing Esports and gaming market in Latin America

Mobius Interactive, an online Esports and gaming operator, is expanding into the Brazilian market. The Company announced in a recent press release (https://ibn.fm/Pj2uL) that the Mobius.Bet brand will be displayed prominently in every stadium and on Globo TV for all eight World Cup qualifiers in Latin America. Soccer is the biggest sport in the world and Brazil is a soccer powerhouse. Brazil holds more World Cup victories than any other team; they have qualified for every World Cup they have entered.

The 2021 qualifiers begin June 3 and run through November 16. These critical matches will attract an average audience of…

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Collaborating to Potentially Uncover Innovative New Treatment Options

May 14, 2021

May 14, 2021 11:44:36

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, recently began a collaboration with JelikaLite in a clinical trial. The clinical trial, which has 30 participants from two New York City locations, is designed to potentially uncover new treatment options to reduce autism symptoms in children. “JelikaLite was launched by medical researchers and practitioners specializing in psychology, neurology and phototherapy. The company has developed an innovative solution to potentially reduce autism symptoms and is developing a home-based system that combines a therapeutic wearable device called Cognilum(TM) with an AI-personalized platform. . . Cognilum delivers treatments through transcranial photobiomodulation, also known as PBM therapy. Using an innovative red and near-infrared light treatment, cellular function is stimulated. This type of therapy is already being used for wound healing, tissue regeneration, inflammation, pain management, hair restoration, skin rejuvenation and restoration of normal cellular function,” reads a recent article. “Through the clinical trial, children diagnosed with autism will receive brain treatments through Cognilum while BRSF’s next-generation NeuroEEG monitors brain activity.”

To view the full article, visit https://ibn.fm/wYCUE

About Brain Scientific Inc.

Brain Scientific is a commercial-stage health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

RYAH Group Inc. (CSE: RYAH) Releases “April 2021 Patients Patterns in New York Report” to Provide Data-Driven Insights Amid Latest Legislation Change

May 14, 2021

May 14, 2021 11:37:02

RYAH has released April 2021 Patients Patterns in New York Report to bring invaluable data-driven insights within the plant-based health industry amid recent recreational cannabis legislation change in this state.
The company leveraged data from 4,387 New York patients within the RYAH Data ecosystem to discover New York-based patients’ profiles, including their preferences and medical reasons for use.
As an authority in dose-control technology for plant-based medicine, RYAH appears well placed to capitalize on growing market opportunities.

RYAH Group (CSE: RYAH) (formerly known as Prime Blockchain Inc.) has announced the release of its “April 2021 Patients Patterns in New York Report,” covering data generated by 4,387 patients from New York who logged their sessions within the RYAH Data ecosystem between January 1, 2018, and April 15, 2021 (https://cnw.fm/wMmGf). As an authority within the dose-control technology for plant-based medicine, RYAH leverages access to a wealth of data helping open up new knowledge-enabled possibilities within the health industry. The newly published report is the latest such initiative — especially invaluable since the recent legislative approval of recreational cannabis in March 2021.

Home to one of the wealthiest cities in the world, New York state accounts for 8% of US GDP. It is expected to become one of the largest US plant markets, with recreational cannabis sales potentially reaching…